Terms: = Bone cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
138 results:
1. bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
Paindelli C; Parietti V; Barrios S; Shepherd P; Pan T; Wang WL; Satcher RL; Logothetis CJ; Navone N; Campbell MT; Mikos AG; Dondossola E
Acta Biomater; 2024 Apr; 178():83-92. PubMed ID: 38387748
[TBL] [Abstract] [Full Text] [Related]
2. 3D-Printed Magnesium Peroxide-Incorporated Scaffolds with Sustained Oxygen Release and Enhanced Photothermal Performance for Osteosarcoma Multimodal Treatments.
Haixia X; Peng Z; Jiezhao L; Huiling G; Xie C; Yihan W; Yanglei J; Li J; Wang C; Wenning X; Lixin Z; Liu C
ACS Appl Mater Interfaces; 2024 Feb; 16(8):9626-9639. PubMed ID: 38372238
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Gastric cancer with Pulmonary Carcinomatous Lymphangitis and Disseminated Carcinomatosis of the bone Marrow Responding to S-1 plus Cisplatin Chemotherapy].
Otsuka N; Shirayama K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1319-1321. PubMed ID: 38247072
[TBL] [Abstract] [Full Text] [Related]
4. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract] [Full Text] [Related]
5. flt4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia.
Lee JY; Lee SE; Han AR; Lee J; Yoon YS; Kim HJ
Haematologica; 2023 Nov; 108(11):2933-2945. PubMed ID: 37317880
[TBL] [Abstract] [Full Text] [Related]
6. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract] [Full Text] [Related]
7. A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration.
Gong M; Huang Y; Feng H; Lin J; Huang A; Hu J; Tang Q; Zhu X; Han S; Lu J; Wang J
J Control Release; 2023 Mar; 355():68-84. PubMed ID: 36682726
[TBL] [Abstract] [Full Text] [Related]
8. Invasion and Secondary Site Colonization as a Function of In Vitro Primary Tumor Matrix Stiffness: Breast to bone Metastasis.
Shah L; Latif A; Williams KJ; Mancuso E; Tirella A
Adv Healthc Mater; 2023 Jan; 12(3):e2201898. PubMed ID: 36351739
[TBL] [Abstract] [Full Text] [Related]
9. Dual-Modal Imaging and Synergistic Spinal Tumor Therapy Enabled by Hierarchical-Structured Nanofibers with Cascade Release and Postoperative Anti-adhesion.
Qian J; Su L; He J; Ruan R; Wang J; Wang Z; Xiao P; Liu C; Cao Y; Li W; Zhang J; Song J; Yang H
ACS Nano; 2022 Oct; 16(10):16880-16897. PubMed ID: 36136320
[TBL] [Abstract] [Full Text] [Related]
10. Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome.
Knight R; Board-Davies E; Brown H; Clayton A; Davis T; Karatas B; Burston J; Tabi Z; Falcon-Perez JM; Paisey S; Stephens P
Stem Cells Transl Med; 2022 Aug; 11(8):861-875. PubMed ID: 35716044
[TBL] [Abstract] [Full Text] [Related]
11. Engineer a pre-metastatic niched microenvironment to attract breast cancer cells by utilizing a 3D printed polycaprolactone/nano-hydroxyapatite osteogenic scaffold - An in vitro model system for proof of concept.
Xiong Q; Zhang N; Zhang M; Wang M; Wang L; Fan Y; Lin CY
J Biomed Mater Res B Appl Biomater; 2022 Jul; 110(7):1604-1614. PubMed ID: 35112785
[TBL] [Abstract] [Full Text] [Related]
12. Breast cancer Cells Metastasize to the Tissue-Engineered Premetastatic Niche by Using an Osteoid-Formed Polycaprolactone/Nanohydroxyapatite Scaffold.
Xiong Q; Wang M; Liu J; Lin CY
Comput Math Methods Med; 2021; 2021():9354202. PubMed ID: 34938359
[TBL] [Abstract] [Full Text] [Related]
13. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract] [Full Text] [Related]
14. Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.
Errichetti E; Geller S; Zalaudek I; Longo C; Kyrgidis A; Akay BN; Piccolo V; Myskowski P; Vitiello P; Russo T; Argenziano G; Sławińska M; Sokołowska-Wojdyło M; Sobjanek M; Toncic RJ; Rados J; Drvar DL; Ceovic R; Kaminska-Winciorek G; Zaballos P; Reggiani C; Kremic Z; Lanssens S; Güleç AT; Lobato-Berezo A; Damiani G; Maione V; Calzavara-Pinton P; Sotiriou E; Stinco G; Apalla Z; Lallas A
J Am Acad Dermatol; 2022 Apr; 86(4):774-781. PubMed ID: 34695527
[TBL] [Abstract] [Full Text] [Related]
15. flt4/vegfr3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for bacterial elimination.
Ma L; Li W; Zhang Y; Qi L; Zhao Q; Li N; Lu Y; Zhang L; Zhou F; Wu Y; He Y; Yu H; He Y; Wei B; Wang H
Autophagy; 2022 Jun; 18(6):1385-1400. PubMed ID: 34632918
[TBL] [Abstract] [Full Text] [Related]
16. Shape-memory balloon offering simultaneous thermo/chemotherapies to improve anti-osteosarcoma efficacy.
Ouchi S; Niiyama E; Sugo K; Uto K; Takenaka S; Kikuchi A; Ebara M
Biomater Sci; 2021 Oct; 9(20):6957-6965. PubMed ID: 34546257
[TBL] [Abstract] [Full Text] [Related]
17. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R; Jelinek T; Kralova R; Stork M; Polackova P; Vsianska P; Brozova L; Jarkovsky J; Almasi M; Boichuk I; Knechtova Z; Penka M; Pour L; Sevcikova S; Hajek R; Rihova L
Br J Haematol; 2021 Oct; 195(1):95-107. PubMed ID: 34500493
[TBL] [Abstract] [Full Text] [Related]
18. 3D Printed Wesselsite Nanosheets Functionalized Scaffold Facilitates NIR-II Photothermal Therapy and Vascularized bone Regeneration.
Yang C; Ma H; Wang Z; Younis MR; Liu C; Wu C; Luo Y; Huang P
Adv Sci (Weinh); 2021 Oct; 8(20):e2100894. PubMed ID: 34396718
[TBL] [Abstract] [Full Text] [Related]
19. Magnetic bioactive glasses/Cisplatin loaded-chitosan (CS)-grafted- poly (ε-caprolactone) nanofibers against bone cancer treatment.
Amini Z; Rudsary SS; Shahraeini SS; Dizaji BF; Goleij P; Bakhtiari A; Irani M; Sharifianjazi F
Carbohydr Polym; 2021 Apr; 258():117680. PubMed ID: 33593554
[TBL] [Abstract] [Full Text] [Related]
20. 3D Tissue-Engineered Tumor Model for Ewing's Sarcoma That Incorporates bone-like ECM and Mineralization.
Molina ER; Chim LK; Salazar MC; Koons GL; Menegaz BA; Ruiz-Velasco A; Lamhamedi-Cherradi SE; Vetter AM; Satish T; Cuglievan B; Smoak MM; Scott DW; Ludwig JA; Mikos AG
ACS Biomater Sci Eng; 2020 Jan; 6(1):539-552. PubMed ID: 33463239
[TBL] [Abstract] [Full Text] [Related]
[Next]
